2023-03-26 16:00:03
Latest Post
Zydus Lifesciences Ltd gets 3 observations from USFDA for Pharmex, Ahmedabad facility
Lupin announces Successful Completion of UK MHRA Inspection of its Pithampur Facilities
Kalyan Jewellers' brand ambassador Rashmika Mandanna inaugurates showroom at Vaishali Nagar, Jaipur
Motisons Jewellers files DRHP for IPO
PM inaugurates the RuPay National Common Mobility Card for Bangalore Metro with RBL Bank as Issuing Bank
Stock Report
Caprihans India Ltd posts loss in Q3FY23
Posted On : 2023-02-08 00:40:02( TIMEZONE : IST )
CAPRIHANS INDIA LTD. has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 85.4031 crores during the period ended December 31, 2022 as compared to Rs. 93.5769 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. -0.9352 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 5.7171 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. -0.71 for the period ended December 31, 2022 as compared to Rs. 4.35 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹85.4031 crs | ₹93.5769 crs |  -8.73% |
| Net Profit | ₹-0.9352 crs | ₹5.7171 crs | -116.36% |
| EPS | ₹-0.71 | ₹4.35 | -116.32% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.85.4031 crores during the period ended December 31, 2022 as compared to Rs.100.2086 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.-0.9352 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.5.0428 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.-0.71 for the period ended December 31, 2022 as compared to Rs.3.84 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹85.4031 crs | ₹100.2086 crs | -14.77% |
| Net Profit | ₹-0.9352 crs | ₹5.0428 crs | -118.55% |
| EPS | ₹-0.71 | ₹3.84 | -118.49% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.290.0227 crores during the 9 Months period ended December 31, 2022 as compared to Rs.282.3958 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.6.3262 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.11.9505 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.4.82 for the 9 Months period ended December 31, 2022 as compared to Rs.9.10 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹290.0227 crs | ₹282.3958 crs |  2.70% |
| Net Profit | ₹6.3262 crs | ₹11.9505 crs | -47.06% |
| EPS | ₹4.82 | ₹9.10 | -47.03% |
Shares of CAPRIHANS INDIA LTD. was last trading in BSE at Rs. 117.65 as compared to the previous close of Rs. 125.65. The total number of shares traded during the day was 14255 in over 138 trades.
The stock hit an intraday high of Rs. 127.90 and intraday low of 114.95. The net turnover during the day was Rs. 1685956.00.
